Geographic Atrophy Market: Growth Trends and Forecast

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Geographic Atrophy Market Between 2026 And 2030?

The geographic atrophy market size has experienced rapid growth in recent years. It is projected to expand from $2.11 billion in 2025 to $2.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.3%. This historic growth can be attributed to factors such as the increase in the aging population, the prevalence of age-related macular degeneration, advancements in retinal imaging, early ophthalmic drug development efforts, and clinical research funding.

The geographic atrophy market size is anticipated to undergo swift expansion in the upcoming years. It is forecast to achieve a value of $3.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.1%. The growth anticipated during this forecast period can be ascribed to several factors, including the approval of innovative therapies, the broadening of screening programs, the incorporation of AI-based imaging solutions, heightened patient awareness, and the advancement of specialty eye care. Significant trends expected in the forecast period involve the increasing development of complement inhibitor treatments, a concentrated effort on the early diagnosis of retinal disorders, augmented investment in new ophthalmic drugs, the wider adoption of imaging technologies for tracking disease progression, and a rise in clinical trials for AMD treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/geographic-atrophy-global-market-report

What Factors Are Contributing To The Growth Of The Geographic Atrophy Market?

The rising prevalence of age-related macular degeneration is anticipated to drive the expansion of the geographic atrophy market in the coming period. Age-related macular degeneration (AMD) is an ocular condition that harms the central part of the retina in older individuals, making it challenging to see intricate details. The aging demographic serves as a primary driver for the widespread occurrence of age-related macular degeneration, given that increased longevity and the natural aging process progressively damage the eyes, rendering them more susceptible to the disease over time. Treatments for geographic atrophy assist age-related macular degeneration (AMD) patients by decelerating the progression of retinal damage and safeguarding their existing vision. For instance, in January 2024, a report published by Medical News Today, a US-based digital media company, forecast that global cases of age-related macular degeneration are expected to increase from 196 million to 288 million by 2040. Consequently, the escalating prevalence of age-related macular degeneration is fueling the growth of the geographic atrophy market.

How Is The Geographic Atrophy Market Broken Down By Segment Categories?

The geographic atrophy market covered in this report is segmented –

1) By Drug Type: Anti-Vascular Endothelial Growth Factor (VEGF) Therapy, Complement Inhibitors, Neuroprotective Agents, Other Drug Types

2) By Diagnosis: Fundus Autofluorescence (FAF), Optical Coherence Tomography Angiography (OCT-A), Multifocal Electroretinography (mfERG)

3) By Route Of Administration: Intravitreal, Oral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:

1) By Anti-Vascular Endothelial Growth Factor (VEGF) Therapy: Ranibizumab, Aflibercept, Bevacizumab

2) By Complement Inhibitors: Pegcetacoplan, Lfg316

3) By Neuroprotective Agents: Latanoprost, Brimonidine

4) By Other Drug Types: Steroids, Retinoids, Combination Therapy

What Trends Are Shaping The Future Of The Geographic Atrophy Market?

Major companies operating in the geographic atrophy market are concentrating on innovative therapies like complement inhibitor therapy to develop advanced treatments for geographic atrophy. Complement inhibitor therapy is a treatment designed to slow an overactive immune response linked to certain diseases, helping to protect healthy cells from damage and reduce disease progression. For instance, in February 2025, Astellas Pharma Inc., a Japan-based pharmaceutical company, announced that IZERVAY (avacincaptad pegol intravitreal solution) for geographic atrophy received approval from the Food and Drug Administration, a US-based government agency. This approval permits IZERVAY to be utilized without a limitation on the duration of dosing for treating geographic atrophy (GA) secondary to age-related macular degeneration (AMD). This decision offers enhanced flexibility for managing GA, providing longer-term treatment options for both patients and healthcare providers.

Which Players Are Present In The Geographic Atrophy Market Space?

Major companies operating in the geographic atrophy market are Regeneron Pharmaceuticals Inc, Ocugen Inc, Kodiak Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio, Graybug Vision, SparingVision, Alkeus Pharmaceuticals, Kiora Pharmaceuticals, Nanoscope Therapeutics, 4D Molecular Therapeutics, Gensight Biologics, BioMarin Pharmaceutical Inc, Nightstar Therapeutics, MeiraGTx, Retinagenix Inc, Adverum Biotechnologies, AGTC Inc, Editas Therapeutics

Get The Full Geographic Atrophy Market Report:

https://www.thebusinessresearchcompany.com/report/geographic-atrophy-global-market-report

Which Region Leads The Geographic Atrophy Market In Terms Of Market Share?

North America was the largest region in the geographic atrophy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the geographic atrophy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Geographic Atrophy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/geographic-atrophy-global-market-report

Browse Through More Reports Similar to the Global Geographic Atrophy Market 2026, By The Business Research Company

Athleisure Market Report 2026

https://www.thebusinessresearchcompany.com/report/athleisure-global-market-report

Geographic Information System Market Report 2026

https://www.thebusinessresearchcompany.com/report/geographic-information-system-global-market-report

Geotourism Market Report 2026

https://www.thebusinessresearchcompany.com/report/geotourism-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795